General MedicationsINJECTIONGeneric
PENTACEF
CEFTAZIDIME
Standard Dose
10GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PENTACEF is listed in Drugs@FDA under application 064008 (ANDA).
Marketing status: Discontinued Active ingredient CEFTAZIDIME Form and strength INJECTABLE;INJECTION - 10GM/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview PENTACEF is listed in Drugs@FDA under application 064008 (ANDA). Marketing status: Discontinued Active ingredient CEFTAZIDIME Form and strength INJECTABLE;INJECTION - 10GM/VIAL Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.